Even non-diabetics, specifically those taking semaglutide (known by its brand names Ozempic and Wegovy), also had a lower likelihood of depression and anxiety.
"These primary data provide a new perspective for understanding the antidepressant-like effects of dulaglutide and may facilitate the use of dulaglutide as a potential therapeutic strategy for depression," the researchers write in their paper.
[
add
]
[
|
|
...
]